市場データを読み込み中...
2026年8月30日日曜日
ホームへ戻るNewsAmorepacificの記事をすべて見る

K-Beauty M&A Trap: Western Giants Watch Brands Wither as Domestic Players Eye Buybacks

執筆 MinJeKim

この記事の日本語訳は準備中です。以下は英語の原文です。

K-Beauty M&A Trap: Western Giants Watch Brands Wither as Domestic Players Eye Buybacks

Western Beauty Giants Confront Costly Lesson in Korean Brand Management

The global beauty M&A wave that saw Unilever, Estée Lauder, and L'Oréal pour billions of dollars into Korean cosmetics brands between 2017 and 2021 is now exposing its fault lines. A decade after the first marquee deals closed, all three multinationals are grappling with declining performance at their Korean acquisitions — and domestic operators are beginning to circle the assets at steep discounts.

The most striking illustration is Estée Lauder's Dr. Jart+. The dermatology-inspired skincare brand, which the New York-based beauty group gradually acquired between 2015 and 2021, is now being discussed in the market at approximately USD 130 million — less than one-sixth of its 2019 peak valuation, according to people familiar with the matter. The Founders Inc., the Seoul-based beauty incubator behind the fast-growing Anua brand, is reportedly exploring an acquisition, KED Global reported on June 23.

The story echoes across multiple brands. Unilever paid €2.27 billion (approximately USD 2.7 billion) for Carver Korea — owner of the AHC skincare franchise — in 2017, betting on the brand's strong following among Asian millennials. L'Oréal acquired Stylenanda, the Korean lifestyle company behind the 3CE makeup brand, in 2018. AHC, Dr. Jart+, Dr.G, and 3CE have all since seen earnings decline, according to industry sources cited by KED Global, squeezed between weakening demand from China and what insiders describe as multinational conglomerates' rigid corporate practices.

Why the K-Beauty Formula Breaks Down Under Western Ownership

The failure pattern runs deeper than any individual brand misstep. K-beauty's competitive edge depends on short innovation cycles — brands typically launch new SKUs every four to eight weeks — hyper-responsive product development tied to real-time social media signals, and a direct feedback loop with Korean retailers and content creators. When those brands transfer to the umbrella of large Western corporations, with their multi-tier approval chains, centralised R&D governance, and globally standardised marketing playbooks, that agility erodes.

All three major acquisitions also coincided with a period of peak Chinese cross-border e-commerce demand for Korean beauty products. As China's domestic economy cooled and the novelty premium attached to K-beauty faded in that market, the revenue trajectories underpinning those deal valuations were exposed. For brands under Western ownership, the ability to rapidly pivot — launching China-specific formulations, leaning into live-commerce platforms, or partnering with domestic Chinese daigou networks — was constrained by headquarters approval requirements that Korean-run operators do not face.

Domestic Operators Circle Back

The calculus is now reversing. The Founders' potential bid for Dr. Jart+ represents part of a broader thesis in Korean investment circles: domestic operators, running leaner structures and retaining cultural proximity to both the brands and their target consumers, may be better positioned to revive faded properties than the Western groups that originally acquired them.

K-beauty M&A activity reached a post-COVID record in 2025, with 26 deals totalling USD 1.8 billion according to industry data. But the character of that activity is shifting: from foreign buyers paying peak-cycle premiums to domestic operators selectively acquiring distressed assets that still carry genuine brand equity and name recognition.

For investors tracking the Korean cosmetics sector on KOSPI, the reversal has broader implications. Amorepacific Corp. (090430.KS) and LG H&H Co. (051900.KS) — both of which pursued largely organic brand-building strategies and retained ownership of their key franchises rather than selling to multinationals — may emerge as structural beneficiaries as the K-beauty brand ecosystem realigns around domestic ownership models. Their refusal to sell at peak valuations, once criticised by some investors as forgoing liquidity events, now looks prescient.

Sources

見出しの先を読む

何が起きたかは読みました。次は、それが何を意味するかを。

無料デイリーブリーフィング

米国市場を毎朝 — 無料で

LineVest Dailyが寄付き前に届きます:米国市場の主要ストーリー、決算、開示、外国人フロー — わかりやすい英語で。無料、カード登録不要。

LineVest Dailyを無料で →
この企業

Amorepacific Corp.の詳細レポート

Amorepacific Corp.の最新SEC開示を全て読み込みます — US GAAPの財務、ガバナンス、株価への意味まで。3時間以内にPDFでお届け。

$12・買い切り

Amorepacific Corp.レポートを入手
ウォッチ銘柄すべて

市場全体をフォロー

週に何銘柄も米国株を見ていますか?すべての分析記事を公開と同時に — デイリーの米国市場全カバレッジと90日アーカイブ。

$9.99・月額

購読する

一次資料のSEC開示に基づく独立ジャーナリズム — 投資助言ではありません。証券会社との提携はありません。

関連記事

ファイザー・ビオンテック、FDA がコミナティ XFG を承認――Q2 売上高 34% 減、Q4 が正念場
ニュース

ファイザー・ビオンテック、FDA がコミナティ XFG を承認――Q2 売上高 34% 減、Q4 が正念場

アルタ・ビューティー(ULTA)FY2026第2四半期決算:予想超えかつガイダンス引き上げ、なぜ株価は4%下落したか?
ニュース

アルタ・ビューティー(ULTA)FY2026第2四半期決算:予想超えかつガイダンス引き上げ、なぜ株価は4%下落したか?

フィリップ・モリスとアルトリアが製造提携を再構築――デューティ・ドローバック契約がPMとMOに意味するもの
ニュース

フィリップ・モリスとアルトリアが製造提携を再構築――デューティ・ドローバック契約がPMとMOに意味するもの

トランプ、ベネズエラ石油合意を発表――CVXが新油田2か所に接近、SLBは署名済み、HALは交渉中
ニュース

トランプ、ベネズエラ石油合意を発表――CVXが新油田2か所に接近、SLBは署名済み、HALは交渉中

GoogleがDMA制裁金回避へEEAスパムポリシーを改定――GOOGL投資家が知るべきこと
ニュース

GoogleがDMA制裁金回避へEEAスパムポリシーを改定――GOOGL投資家が知るべきこと

オートデスク(ADSK)Q2 FY2027:売上高・EPSは予想超えも、cRPO成長率12%に減速——株価5%下落
ニュース

オートデスク(ADSK)Q2 FY2027:売上高・EPSは予想超えも、cRPO成長率12%に減速——株価5%下落

ウォーシュ議長、ジャクソンホールで「やるべき仕事がある」—9月利上げ確率が57%超に急上昇
ニュース

ウォーシュ議長、ジャクソンホールで「やるべき仕事がある」—9月利上げ確率が57%超に急上昇

ウォルマート、5年超の連邦オピオイド訴訟で司法省と和解――条件は非公開、株価は小幅高
ニュース

ウォルマート、5年超の連邦オピオイド訴訟で司法省と和解――条件は非公開、株価は小幅高

キンバリー・クラーク、487億ドルのケンビュー買収でEU期限9月29日・中国SAMR審査リスク浮上
ニュース

キンバリー・クラーク、487億ドルのケンビュー買収でEU期限9月29日・中国SAMR審査リスク浮上

エヌビディア、Hugging Face買収に向け最終交渉段階か―買収総額129億ドル
ニュース

エヌビディア、Hugging Face買収に向け最終交渉段階か―買収総額129億ドル

アドベントとStripeがPayPal(PYPL)への60.50ドル買収提案を断念
ニュース

アドベントとStripeがPayPal(PYPL)への60.50ドル買収提案を断念

モデルナ(MRNA)、9.2%ローンの後に最大23億ドルのゼロ金利募集を計画
ニュース

モデルナ(MRNA)、9.2%ローンの後に最大23億ドルのゼロ金利募集を計画